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Oxidative stress, an imbalance resulting from increased prooxidant generation and/or decreased antioxidant defenses, is
implicated in the pathogenesis of numerous diseases, including
atherosclerosis, diabetes, hemochromatosis, ischemic reperfusion injury, and rheumatoid arthritis, and in the normal aging
process (1). In atherosclerosis, the oxidation of circulating low
density lipoproteins (LDLs)1 and their increased uptake by the
scavenger receptor is thought to promote the deposition of
lipid-laden macrophages in the vascular wall, leading to fatty
streaks that precede the development of plaque (2). In diabetes,
oxidative stress, resulting from the metabolic sequelae of hy-
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1
The abbreviations used are: LDL, low density lipoprotein; AGE,
advanced glycation end product; CML, N e-(carboxymethyl)lysine; FL,
e
N -(fructose)lysine; RNase, bovine pancreatic ribonuclease A; GC/MS,
gas chromatography-mass spectrometry; PBS, phosphate-buffered
saline (12); PUFA, polyunsaturated fatty acid; HPLC, high pressure
liquid chromatography.

perglycemia and/or nonenzymatic glycation of protein, leads to
increased formation of advanced glycation end products (AGEs)
in tissue proteins (3, 4). Among these AGEs are the glycoxidation products, N e-(carboxymethyl)lysine (CML) and pentosidine, which are the only chemically characterized AGEs known
to accumulate in protein with age and at an accelerated rate in
diabetes (5). Glycation and glycoxidation products and AGEs
affect the structure and function of proteins and cross-linking
of extracellular proteins, processes that are thought to contribute to the pathogenesis of vascular disease in diabetes and
atherosclerosis (3–5).
The observations that the extent of glycation of plasma proteins, including LDL, is increased in diabetes (6) and that
glycated proteins are redox-active and may thus catalyze lipid
peroxidation reactions have suggested that increased glycation
of LDL in diabetes might accelerate its oxidation, providing a
mechanism for the excess risk for atherosclerosis associated
with diabetes (7). Other studies have shown that plasma antioxidant defenses, including ascorbic acid and vitamin E concentrations, and total radical trapping activity are also compromised in diabetes (8). Although the combination of
increased glycation of LDL and decreased antioxidant defenses
in diabetic plasma provides the potential for catalysis of lipid
peroxidation in plasma lipoproteins, there is no direct evidence
of a correlation between glycation and enhanced oxidation of
LDL in diabetes.
In an effort to understand the potential interplay between
glycation and lipid peroxidation reactions, we initiated studies
on how changes in levels of glycation affect lipid peroxidation
and formation of glycoxidation products during metal-catalyzed oxidation of LDL in vitro. We report here the unexpected
observation that CML is formed during copper-mediated oxidation of LDL, independent of the presence of the putative
carbohydrate precursor, the Amadori compound fructoselysine
(FL). We also report that CML, heretofore described as a glycoxidation product, is formed during peroxidation of polyunsaturated fatty acids (PUFA) in the presence of ribonuclease A
(RNase), a protein that contains neither enzymatically nor
nonenzymatically attached carbohydrate.
MATERIALS AND METHODS

Reagents—The following reagents were purchased from Sigma: diethylenetriaminepentaacetic acid, arachidonic acid, linoleic acid, oleic
acid, and bovine pancreatic ribonuclease A (RNase, type II-A). Girard T
reagent ((carboxymethyl)trimethyl-ammonium chloride) and glyoxal
(40% monomer solution) were from Aldrich. CML and FL standards
were synthesized as described (9).
Preparation and Copper Oxidation of LDL—Blood was obtained from
healthy volunteers after an overnight fast. Blood was collected in EDTA
(1.5 mg/ml), and plasma was separated by centrifugation. LDL was
isolated by single vertical spin centrifugation (10), stored at 4 °C under
nitrogen, and used within 48 h of isolation. The purity of LDL preparations was confirmed by agarose gel electrophoresis followed by stain-
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N e-(Carboxymethyl)lysine (CML) is an advanced glycation end product formed on protein by combined nonenzymatic glycation and oxidation (glycoxidation) reactions. We now report that CML is also formed during
metal-catalyzed oxidation of polyunsaturated fatty
acids in the presence of protein. During copper-catalyzed oxidation in vitro, the CML content of low density
lipoprotein increased in concert with conjugated dienes
but was independent of the presence of the Amadori
compound, fructoselysine, on the protein. CML was also
formed in a time-dependent manner in RNase incubated
under aerobic conditions in phosphate buffer containing arachidonate or linoleate; only trace amounts of
CML were formed from oleate. After 6 days of incubation
the yield of CML in RNase from arachidonate was ;0.7
mmol/mol lysine compared with only 0.03 mmol/mol lysine for protein incubated under the same conditions
with glucose. Glyoxal, a known precursor of CML, was
also formed during incubation of RNase with arachidonate. These results suggest that lipid peroxidation, as
well as glycoxidation, may be an important source of
CML in tissue proteins in vivo and that CML may be a
general marker of oxidative stress and long term damage to protein in aging, atherosclerosis, and diabetes.

CML as a Lipoxidation and Glycoxidation Biomarker

RESULTS

Fig. 1 describes the kinetics of metal-catalyzed oxidation of
normal LDL and concurrent changes in the protein’s content of
CML and FL. Comparison of the kinetics of conjugated diene
(panel A) and CML (panel B) formation indicates that the rate
of CML formation parallels the rate of fatty acid peroxidation.
Neither conjugated dienes nor CML increased in the absence of
copper. Because we assumed initially that the CML was derived from oxidation of the Amadori adduct on LDL, the FL
content of the protein was also measured at various stages in
the oxidation reaction. The data in panel C demonstrate unexpectedly that, unlike CML, the FL content of LDL remained
constant during the course of the copper oxidation. We concluded tentatively that the CML was being formed from a
product of oxidation of the lipid component of the LDL. To
verify that CML could be formed independent of the presence of

FIG. 1. Copper-catalyzed oxidation of LDL results in an increase in CML without a change in the FL content of the protein. LDL was incubated with (open symbols) or without (closed symbols) 5 mM copper at 32 °C. The progress of the oxidation reaction was
monitored by following conjugated diene formation at 234 nm (A). The
amounts of CML (B) and FL (C) were measured by GC/MS as described
under “Materials and Methods.” Data are shown for two different pools
of LDL.

FL, the LDL was reduced with NaBH4 to convert FL to the
inert, redox-inactive hexitollysine adduct. Table I shows that
#5% of the original FL remained on the reduced LDL, yet
following oxidation of the reduced lipoprotein, the yield of CML
was similar to that formed during oxidation of the native protein. The absorbance traces during metal-catalyzed oxidation of
NaBH4-reduced LDL were similar to those of the native protein
(data not shown). These results indicate that CML can be
formed on lipoprotein from product(s) of PUFA oxidation.
To further characterize the formation of CML during lipoxidation reactions, model experiments were carried out in which
PUFAs were oxidized in the presence of RNase A, a protein
devoid of carbohydrate. As shown in Fig. 2, oxidation of linoleate and arachidonate in the presence of RNase yielded a timedependent increase in CML residues in the protein. In these
experiments the fatty acids were progressively solubilized in
buffer as they autoxidized, and the experiments were arbitrarily terminated at 6 days when the arachidonate reactions
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ing for both lipid and protein using a Paragon LIPOEPG system (Beckman Instruments, Palo Alto, CA), which showed a single lipid and
protein band; contamination with albumin was not detected. LDL protein concentration was estimated by the method of Lowry (11). LDL
pools were prepared by combining LDL from three individuals.
To remove salts, EDTA, and water-soluble antioxidants prior to
copper oxidation experiments, LDL was chromatographed on PD-10
columns (Pharmacia Biotech Inc.) equilibrated in phosphate-buffered
saline (PBS; Ref. 12) that had been gassed with nitrogen. The LDL was
sterilized by ultrafiltration (0.22-m filters, CoStar, Cambridge, MA) and
then diluted to ;100 mg of protein/ml using PBS that had been bubbled
with oxygen for at least 10 min. The diluted samples were adjusted to
5 mM CuCl2, placed in loosely capped plastic bottles, and incubated at
32 °C; copper was omitted in control samples. The progress of the
oxidation reaction was monitored by measuring absorbance at 234 nm
in aliquots removed at various times. For analysis of CML, aliquots (;1
mg of protein) were adjusted to 1 mM in diethylenetriaminepentaacetic
acid (0.1 M) in sodium borate, pH 9.2, and reduced overnight at 4 °C
with a final concentration of 25 mM NaBH4. The samples were then
dialyzed against water, dried by centrifugal evaporation (Savant SpeedVac, Farmingdale, NY), and delipidated using methanol:ether (3:10)
(13). For analyses of FL, samples were treated with diethylenetriaminepentaacetic acid, dialyzed immediately, dried, and delipidated.
Modification of RNase with Fatty Acids or Glucose—Reaction mixtures, in triplicate, were prepared containing 1 mM RNase (equal to 10
mM lysine) and either 100 mM fatty acid or 100 mM glucose in PBS. The
required amounts of fatty acids dissolved in CHCl3 were placed in
sterile 20-ml glass scintillation vials, and the solvent was removed
under a stream of nitrogen passed through a 0.22-m filter. All subsequent additions and the removal of sample aliquots at various times
were conducted using sterile technique in a tissue culture hood. Solutions of RNase or glucose prepared in sterile PBS were sterilized by
ultrafiltration (0.22-m filter) and added as appropriate to the vials
containing fatty acid. The vials were covered with sterile caps and
placed in a shaking water bath at 37 °C. Aliquots (0.2– 0.4 ml) were
removed at desired times and processed immediately. Fatty acids were
removed by Folch extraction (14). The aqueous layer and protein interface from the Folch extracts were back-extracted with theoretical Folch
lower phases and dialyzed against water, and the protein was then
processed for measurement of CML. To limit oxidation of FL to CML
during sample hydrolysis, aliquots of protein incubated with glucose
were first reduced with NaBH4 prior to measurement of CML (9).
Recovery of CML in protein incubated with fatty acids only was unaffected by prior reduction with NaBH4. In some experiments a second
aliquot (0.7 ml) was used for measurement of glyoxal. Following acidification with 25 ml of 3 M HCl and the addition of 100 ml of Girard T
reagent (0.5 N) (16), samples were incubated at room temperature for 1
h and then stored at 220 °C; samples were analyzed by HPLC (16) in a
single batch at the end of the experiment.
Protein Hydrolysis and GC/MS Analyses—Following the addition of
d8-lysine and d8-CML or 13C6-FL internal standards, proteins were
hydrolyzed in 6 N HCl for 24 h at 110 °C. After drying by centrifugal
evaporation, the dried hydrolysates were dissolved in 3 ml of 20%
methanol containing 0.1% trifluoroacetic acid and applied to 3-ml SepPak columns (Supelco, Bellefonte, PA) to remove brown and lipophilic
materials prior to derivatization for GC/MS. The eluates were again
dried and then derivatized for measurement of CML or FL by GC/MS as
their trifluoroacetyl methyl ester derivatives (9).
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TABLE I
Effect of NaBH4 reduction on formation of FL and CML during
copper oxidation of LDL
Sample

Time
h

Native LDLa
Native LDLa
Reduced LDLb
Reduced LDLb

0
24
0
24

FL

CML
mmol/mol lysine

0.76–0.80
0.76–0.84
#0.05
#0.05

0.034–0.059
0.67–1.09
0.043–0.077
0.98–1.1

a
LDL was incubated at 32 °C with 5 mM copper, and samples were
removed at indicated times for measurement of FL and CML as described under “Materials and Methods.” Data are values for two separate experiments.
b
LDL was reduced with NaBH4 in the presence of 1 mM diethylenetriaminepentaacetic acid and then dialyzed against PBS prior to incubation with copper as described above for native LDL. Data are values
for two separate experiments.

FIG. 2. CML is formed during incubation of RNase with PUFA.
RNase (1 mM) was incubated with 100 mM arachidonate (E), linoleate
(M), or oleate (Ç) in PBS at 37 °C, and aliquots were removed at
indicated times. CML was measured by GC/MS as described under
“Materials and Methods.” There was no CML detected in RNase incubated in the absence of fatty acid. Data (mean 6 S.D.) are for single
measurements of individual aliquots from three separate incubations;
absence of error bars indicates error was within size of symbol.

became a single phase. The overall amount of CML formed was
dependent on the degree of unsaturation and oxidizability of
the fatty acid, with the greatest yield of CML formed from
arachidonate, an intermediate yield from linoleate, and only
trace amounts formed from oleate. The difference in yields of
CML from the various fatty acids probably reflects differences
in their extent of oxidation at the end of the experiment.
Because CML was originally identified as a glycoxidation
product (5, 17), i.e. the result of combined glycation and oxidation reactions, we also compared the relative yield of CML from
glucose and arachidonate. Fig. 3 shows that at the end of 6
days’ incubation the yield of CML from autoxidizing arachidonic acid, 0.74 6 0.03 mmol/mol RNase, was significantly
greater than that from glucose, 0.03 6 0.003 mmol/mol RNase.
These results indicate that both carbohydrates and lipids may
contribute to formation of CML during autoxidation reactions
in physiological buffer. However, oxidation of fatty acid is
clearly a more efficient source of CML, despite the fact that the
glucose is in solution throughout the course of the experiment,

while the PUFA are only progressively solubilized. Further,
after 6 days of incubation, a large fraction of the arachidonate
was oxidized based on its solubilization in the aqueous phase,
while #2% of the glucose is oxidized during this same time
period (16). Finally, pentosidine, a second glycoxidation product known to form during glycoxidation reactions in vitro and
in vivo, was detected in incubations of RNase and glucose, but
no pentosidine was detected either in incubations of RNase
with PUFA or in copper-oxidized LDL.
We have previously shown that glyoxal is both a product of
glucose autoxidation and a source of CML in protein (16).
Glyoxal formation has also been reported during UV irradiation of PUFA (18) and during oxidation of linolenic acid in an
iron ascorbate model system (19, 20), although in the latter
case formation of glyoxal from iron ascorbate itself was not
excluded. In the present experiments the formation of glyoxal
from PUFA was monitored by trapping it as the Girard T
adduct (16). The data in Fig. 4 show that there was a progressive increase in the amount of glyoxal formed in autoxidizing
arachidonic acid incubations, which was not significantly affected by the presence of protein. The data also indicate that
the amount of glyoxal formed during arachidonate oxidation
was more than sufficient to account for the amount of CML
formed on protein, if glyoxal were the only source of all the
CML formed.
DISCUSSION

The observations described above indicate that CML, previously described as a glycoxidation product or AGE, may, in fact,
be derived from PUFA during lipid peroxidation reactions.
These observations require a reassessment of previous work on
(a) the biochemical origin of AGEs, (b) the significance of carbohydrate oxidation, autoxidative glycosylation, and glycoxidation in the chemical modification of proteins in diabetes, and, in
general, (c) mechanisms of oxidative stress and pathways of
oxidative damage to protein and other biomolecules in aging,
atherosclerosis, and diabetes.
Biochemical Origin of CML—Our studies indicate that lipid
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FIG. 3. Comparison of CML formation in RNase from arachidonate or glucose. RNase (1 mM) was incubated with 100 mM arachidonate (E, replotted from Fig. 2), or 100 mM glucose (Ç) in PBS. CML
was measured by GC/MS as described under “Materials and Methods.”
Data are expressed as described in the legend to Fig. 2.

CML as a Lipoxidation and Glycoxidation Biomarker

peroxidation is a potential source of CML during lipoprotein
oxidation and is the major source of CML formed during metalcatalyzed oxidation of LDL in vitro. Since PUFAs, both in
biological systems and in vitro (Fig. 3) are, in general, more
easily autoxidized in free radical reactions than are carbohydrates, it is quite possible that the majority of CML in tissue
proteins is derived from lipid peroxidation reactions, even during hyperglycemia when concentrations of glucose and Amadori products on protein are increased. Indeed, the fact that the
FL on LDL was not a significant source of CML formation
during metal-catalyzed oxidation of LDL suggests that glucose
and Amadori adducts may be less important sources of CML in
protein, even in diabetes.
The mechanism of formation of CML and other AGEs during
carbohydrate oxidation reactions is still uncertain. The pathway may involve oxidation of free glucose or protein-bound
intermediates, including carbinolamine, Schiff base, and Amadori adducts (17, 21, 22). Wells-Knecht et al. (16) identified
glyoxal as one intermediate in the formation of CML from
glucose. Since glyoxal is also formed during peroxidation of
PUFA (Refs. 18 –20 and Fig. 4), it may be a common intermediate in the formation of CML during oxidation of both carbohydrates and lipids. However, other common intermediates
may also be involved, such as glycolaldehyde (21), a-hydroxyaldehydes, or b,g-unsaturated a-hydroxyaldehydes or dicarbonyls, which may be formed from both carbohydrate and
PUFA oxidation. The intersection of carbohydrate and lipid
autoxidation reactions in the formation of CML emphasizes the
relationship between the fundamental chemistry and biochemistry of these molecules.
Significance of Lipid Peroxidation Reactions in the Maillard
Reaction in Vivo—The importance of lipid peroxidation in the
formation of AGEs and cross-linking of proteins is suggested by
several experimental observations. The browning and crosslinking of extracellular proteins increase so rapidly in animal
models of diabetes (23) that, in the absence of large endogenous
pools of decompartmentalized transition metal ions, the origin
of the browning products is more readily explained by lipid

rather than carbohydrate oxidation reactions. AGEs also accumulate within a few days on intracellular proteins of cells
grown in high glucose media (24). The rapidity of AGE formation and the effect of antioxidants as inhibitors of acute glucose
toxicity (25) suggests that they may act by inhibiting glucoseinduced lipid peroxidation reactions (26). Finally, it should be
noted that aminoguanidine, which is a potent inhibitor of glycoxidation reactions in vitro (17, 21), the browning and crosslinking of collagen in vivo (23), and the development of complications in diabetic animals (3, 4), also inhibits lipid
peroxidation reactions (27–29) Thus, this compound, which has
been described primarily as an inhibitor of advanced glycation
reactions, may in fact be exerting its effects in vivo by inhibition of lipid peroxidation reactions and/or by trapping of lipid
peroxides and PUFA-derived carbonyl compounds, including
glyoxal.
Mechanisms of Oxidative Stress and Damage in Vivo—Because similar intermediates may be derived from both carbohydrate and lipid peroxidation reactions, it has become difficult
to discern the primary source of oxidative damage to protein in
complex biological matrices. Palinski et al. (30) have recently
reported, for example, that anti-AGE antibodies detect an increase in AGE epitopes in atherosclerotic plaque in normoglycemic animals. Our previous work identifying CML as a major
antigenic determinant in AGE proteins (31) and the present
work identifying CML as a product of lipid peroxidation suggest that the increase in AGE epitopes in atherosclerotic
plaque could result from an increase in CML derived from lipid
peroxidation reactions. In addition, lipid-derived CML may
also be the major AGE epitope accumulating in intracellular
protein in endothelial cells exposed to glucose-induced oxidative stress (24).
To distinguish carbohydrate- from lipid-mediated damage
and assess the relative importance of oxidation of these two
substrates in the development of diabetic complications, it will
be necessary to identify unique products derived from each of
these precursors. In the meantime, since CML has been identified as a major AGE antigen in tissue proteins and a product
of both carbohydrate and lipid peroxidation reactions, our results suggest that CML may be more useful as a general biomarker of oxidative stress and damage in tissue proteins.
REFERENCES
1. Halliwell, B., and Gutteridge, J. M. C. (1989) Free Radicals in Biology and
Medicine, 2nd Ed., Clarendon Press, Oxford
2. Witztum, J. L., and Steinberg, D. (1991) J. Clin. Invest. 88, 1785–1792
3. Brownlee, M. (1994) Diabetes 43, 836 – 841
4. Vlassara, H., Bucala, R., and Striker, L. (1994) Lab. Invest. 70, 138 –151
5. Baynes, J. W. (1991) Diabetes 40, 405– 412
6. Curtiss, L. K., and Witztum, J. L. (1985) Diabetes 34, 452– 461
7. Mullarkey, C. J., Edelstein, D., and Brownlee, M. (1990) Biochem. Biophys.
Res. Commun. 173, 932–939
8. Tsai, E. C., Hirsch, I. B., Brunzell, J. D., and Chait, A. (1994) Diabetes 43,
1010 –1014
9. Knecht, K. J., Dunn, J. A., McFarland, K. F., McCance, D. R., Lyons, T. J.,
Thorpe, S. R., and Baynes, J. W. (1991) Diabetes 40, 190 –196
10. Chung, B. H., Segrest, J. P., Ray, M. J., Brunzell, J. D., Hokanson, J. E.,
Krauss, R. M., Beudrie, K., and Cone, J. T. (1986) Methods Enzymol. 128,
181–209
11. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol.
Chem. 193, 265–275
12. Dulbecco, R., and Vogt, M. S. (1954) J. Exp. Med. 98, 167–173
13. Osborne, J. C. (1986) Methods Enzymol. 128, 213–222
14. Folch, J., Lees, M., and Sloane-Stanley, G. H. (1957) J. Biol. Chem. 226,
497–509
15. Deleted in proof
16. Wells-Knecht, K. J., Zyzak, D. V., Litchfield, J. E. Thorpe, S. R., and Baynes,
J. W. (1995) Biochemistry 34, 3702–3709
17. Fu, M-X, Knecht, K. J., Blackledge, J. A., Lyons, T. J., Thorpe, S. R., and
Baynes, J. W. (1994) Diabetes 43, 676 – 683
18. Niyati-Shirkhodaee, F., and Shibamoto, T. (1993) J. Agric. Food Chem. 41,
227–230
19. Loidl-Stahlhofen, A., and Spiteller, G. (1994) Biochim. Biophys. Acta 1211,
156 –160
20. Mlakar, A., and Spiteller, G. (1994) Biochim. Biophys. Acta 1214, 209 –220
21. Glomb, M. A., and Monnier, V. M. (1995) J. Biol. Chem. 270, 10017–10026
22. Wells-Knecht, M. C., Thorpe, S. R., and Baynes, J. W. (1995) Biochemistry 34,

Downloaded from http://www.jbc.org/ at USC SCHOOL OF MEDICINE on September 30, 2014
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Data are the average 6 range for two separate experiments. For comparison the data from Fig. 2 for CML formation from arachidonate (●),
expressed as mM, are also shown; absence of error bars indicates error
was within size of symbol.
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